Loading clinical trials...
Loading clinical trials...
Differences in Improvements of Knee Range of Motion, Muscle Strength, and Functional Capacity Between Eccentric and Concentric Quadriceps Femoris Exercises in Patients With Knee Osteoarthritis
This study aims to compare the effectiveness of eccentric and concentric quadriceps femoris strengthening exercises in patients with knee osteoarthritis. Knee osteoarthritis is a common musculoskeletal condition that causes pain, reduced joint movement, muscle weakness, and functional limitations. Participants will be assigned to perform either eccentric or concentric unilateral open kinetic chain quadriceps exercises using isotonic loading based on a 10-repetition maximum (10-RM). The exercise program will be conducted three times per week for six weeks. The primary objective is to evaluate differences in quadriceps muscle strength between the two exercise approaches. Secondary outcomes include changes in knee range of motion and functional capacity measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The results of this study are expected to provide evidence to guide exercise prescription in rehabilitation programs for patients with knee osteoarthritis.
Knee osteoarthritis (KOA) is a leading cause of pain, disability, and reduced quality of life among older adults. Quadriceps femoris muscle weakness plays a central role in disease progression and functional impairment. Strengthening exercises are recommended as a core component of conservative management; however, the comparative effects of eccentric versus concentric muscle contractions remain incompletely defined. This interventional comparative study is conducted at the Department of Physical Medicine and Rehabilitation, Dr. Cipto Mangunkusumo National General Hospital, Jakarta. A total of 24 patients diagnosed with knee osteoarthritis based on clinical and radiological criteria are recruited and allocated into two intervention groups. The Eccentric Exercise Group performs unilateral open kinetic chain full-arc quadriceps exercises emphasizing eccentric contraction using the NK Table. The Concentric Exercise Group performs the same exercise emphasizing concentric contraction. Exercise sessions are conducted three times weekly for six weeks. Intensity is determined using a 10-repetition maximum (10-RM) method. During weeks 1-3, participants perform 3 sets of 6 repetitions; during weeks 4-6, the protocol progresses to 3 sets of 8 repetitions. Outcome measures include knee range of motion (measured with a goniometer), quadriceps muscle strength (assessed using the NK Table and recorded in kilograms), and functional capacity (evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index \[WOMAC\]). Measurements are obtained before and after the six-week intervention. The study protocol has received ethical approval from the Ethics Committee of the Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo National General Hospital. All participants provide written informed consent prior to participation.
Age
40 - 59 years
Sex
MALE
Healthy Volunteers
No
Department of Physical Medicine and Rehabilitation
Jakarta, DKI Jakarta, Indonesia
Start Date
July 15, 2024
Primary Completion Date
June 13, 2025
Completion Date
November 21, 2025
Last Updated
March 11, 2026
24
ACTUAL participants
Eccentric Quadriceps Exercise
OTHER
Concentric Quadriceps Exercise
OTHER
Lead Sponsor
Indonesia University
NCT07351968
NCT06747494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06906939